Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Bristol-Myers inks a $350M deal to pair with Five Prime on immuno-oncology gold rush
Bristol-Myers inks a $350M deal to pair with Five Prime on immuno-oncology gold rush
Bristol-Myers inks a $350M deal to pair with Five Prime on immuno-oncology gold rush
Submitted by
admin
on March 17, 2014 - 10:51am
Source:
Fierce Biotech
News Tags:
MK-3475
Merck
Five Prime
cancer immunotherapy
Bristol-Myers Squibb
Headline:
Bristol-Myers inks a $350M deal to pair with Five Prime on immuno-oncology gold rush
Do Not Allow Advertisers to Use My Personal information
